Salute e Benessere
Pertussis Treatment Market Projected to Hit US$ 5.3 Billion by 2034, with a 3.4% CAGR | Fact.MR Report
Pertussis, also known as whooping cough, is an infectious respiratory disease caused by the Bordetella pertussis bacteria. Pertussis mostly affects young children and the older population, and treatment involves medication, vaccination, and supportive care.
Rising prevalence of whooping cough caused by different factors is leading to a high demand for innovative and effective pertussis therapeutic solutions. Drug manufacturers are focused on developing new antibiotics and treatment protocols to combat Bordetella pertussis bacteria. For the same, industry giants are heavily investing in research and development efforts. Targeted antibiotic therapies are the frontline treatments for pertussis infection.
Researchers worldwide are also exploring novel antibiotic classes that can demonstrate efficacy against the Bordetella pertussis bacteria. Combination therapies are expected to offer enhanced treatment outcomes and reduce the likelihood of resistance. Furthermore, the personalized medication trend is also set to offer lucrative growth opportunities for key companies that are involved in providing pertussis treatment solutions.
says a Fact.MR analyst.
Key participants in the pertussis treatment industry are Johnson & Johnson Services Inc.; GlaxoSmithKline, Plc.; Merck & Co. Inc.; Sanofi; Pfizer Inc.; Novartis AG; Panacea Biotech; China National Biotec Group; Changchun Changsheng Life Sciences; Daiichi Sankyo Company Ltd.; Mylan NV; Boehringer Ingelheim International GmbH; Bristol Myers Squibb Company; Mitsubishi Tanabe Pharma; Astellas Pharma; Shenzhen KangTai Biological Products.
Pharmaceutical companies, research institutions, and government healthcare organizations are collaborating for the development and discovery of advanced pertussis medications. These collaborations are aimed at becoming more effective in reducing the ill effects of pertussis and boosting the profits of several stakeholders. International agreements are aimed at the more effective addressing and managing of pertussis globally. These are expected to increase the sales of pertussis therapeutic solutions, especially in high-potential markets such as Latin America and Asia Pacific .
According to an article under scientific reports published by Nature on 16th March 2023 , a pangenome approach-based loop-mediated isothermal amplification assay is proving effective for specific and early detection of pertussis infection.
:
On 25 March 2024 , As per a press release by EurekAlert, researchers from the American Society for Biochemistry and Molecular Biology uncovered a key biomolecule involved in pertussis infection. The discovery is expected to aid in creating a new drug or vaccine for whooping cough.
:
Fact.MR, in its new offering, presents an unbiased analysis of the global pertussis treatment market, presenting historical demand data (2019 to 2023) and forecast statistics for the period (2024 to 2034).
The study divulges essential insights on the market-based treatment type (medications, vaccinations, supportive treatments, others), diagnosis (blood tests, chest X-rays, nose or throat culture & tests), mode of purchase (Rx, OTC), route of administration (oral, parenteral, others), disease stage (incubation stage, catarrhal stage, paroxysmal stage, convalescent stage), and distribution channel (hospital pharmacies, online pharmacies, retail pharmacies), across seven major regions of the world ( North America , Latin America , Western Europe , Eastern Europe , East Asia , South Asia & Pacific, and MEA).
Psychotic Disorder Treatment Market accounts for US$ 13.6 billion and is projected to surge past a valuation of US$ 24.5 billion by the end of 2032.
Alexandrite Laser Treatment Market is calculated at US$ 48.7 million for 2024 and is forecasted to reach US$ 83.2 million by 2034, advancing at a CAGR of 5.5%.
Achalasia Treatment Market Statistics by Treatment (Non-Surgical Treatment, Botulinum Toxin Type A, Pneumatic Dilation, Surgical Treatment, Peroral Endoscopic Myotomy (POEM), Heller Myotomy) & By End User- Global Review 2018 To 2028.
Lewy Body Dementia Treatment Market is predicted to expand steadily at 6% CAGR and reach US$ 8.45 billion by the end of 2033.
Antibiotic-Associated Diarrhea Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2028
Bell's Palsy Treatment Market by Drug Class (Corticosteroids, Anticonvulsants, Antibacterial, Antivirals), Based on Distribution Channel (Hospital, Retail, Drug Stores, Online) - Global Insights to 2028.
is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
: sales@factmr.com
LinkedIn | Twitter | Blog
View original content:https://www.prnewswire.co.uk/news-releases/pertussis-treatment-market-projected-to-hit-us-5-3-billion-by-2034--with-a-3-4-cagr--factmr-report-302209937.html